Literature DB >> 13129634

Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.

Natascha Wachter-Gerstner1, Stefan Wachter, Evi Reinstadler, Claudia Fellner, Tomas H Knocke, Andre Wambersie, Richard Pötter.   

Abstract

PURPOSE: To analyze the correlation between dose-volume histograms based on organ contour and organ wall delineation for bladder and rectum, and to compare the doses to these organs with the absorbed doses at the ICRU bladder and rectum reference points.
MATERIAL AND METHODS: Individual MRI based brachytherapy treatment planning was performed in 15 patients as part of a prospective comparative trial. The external contours and the organ walls were delineated for the bladder and rectum in order to compute the corresponding dose-volume histograms. The minimum dose in 2 cm(3), 5 cm(3) and 10 cm(3) volumes receiving the highest dose were referred to as [D2], [D5] and [D10] and compared with the absorbed dose at the ICRU rectum and bladder reference point.
RESULTS: The bladder (bext) and rectal (rext) doses derived from external contours and computed for volumes of 2 cm(3) [D2], provided a good estimate for the doses computed for the organ walls (bw and rw) only (mean ratio [D2](bext)/[D2](bw)=1.1+/-0.2 and [D2](rext)/[D2](rw)=1.2+/-0.1, respectively). This correspondence was no longer true when larger volumes were considered (5 and 10 cm(3)). The dose at the ICRU rectum reference point did overestimate the dose computed for 2 cm(3) of the rectum wall (mean ratio: 1.5+/-0.4). In contrast, the dose at the ICRU bladder reference point did-in the case of inappropriate topographic location of the balloon-underestimate the dose computed for 2 cm(3) of the bladder wall (overall mean ratio: 0.9+/-0.4).
CONCLUSION: For clinical applications, when volumes smaller than 5 cm(3) are considered, the dose-volume histograms computed from external organ contours for the bladder and rectum can be used instead of dose-volume histograms computed for the organ walls only. External organ contours are indeed easier to obtain. The dose at the ICRU rectum reference point provides a good estimate of the rectal dose computed for volumes smaller than 2 cm(3) [D2] only for a midline position of the rectum. The ICRU bladder reference point provides a good estimate of the dose computed for the bladder wall [D2] only in cases of appropriate balloon position.

Entities:  

Mesh:

Year:  2003        PMID: 13129634     DOI: 10.1016/s0167-8140(03)00189-0

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  21 in total

Review 1.  Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT : part 1.

Authors:  Kerstin A Brocker; Celine D Alt; Michael Eichbaum; Christof Sohn; Hans-Ulrich Kauczor; Peter Hallscheidt
Journal:  Strahlenther Onkol       Date:  2011-09-23       Impact factor: 3.621

2.  Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?

Authors:  V M Patil; F D Patel; S Chakraborty; A S Oinam; S C Sharma
Journal:  Br J Radiol       Date:  2011-05       Impact factor: 3.039

3.  Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning.

Authors:  John M Boyle; Oana Craciunescu; Beverley Steffey; Jing Cai; Junzo Chino
Journal:  Brachytherapy       Date:  2014-01-16       Impact factor: 2.362

4.  Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy.

Authors:  Alexandra J Stewart; Robert A Cormack; Hang Lee; Li Xiong; Jorgen L Hansen; Desmond A O'Farrell; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

5.  Volumetric evaluation of an alternative bladder point in brachytherapy for locally advanced cervical cancer.

Authors:  R Mazeron; J Gilmore; J Champoudry; I Dumas; J Helou; P Maroun; F Martinetti; A Gerbaulet; C Haie-Meder
Journal:  Strahlenther Onkol       Date:  2013-11-17       Impact factor: 3.621

6.  Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.

Authors:  Cem Onal; Gungor Arslan; Erkan Topkan; Berrin Pehlivan; Melek Yavuz; Ezgi Oymak; Aydin Yavuz
Journal:  J Exp Clin Cancer Res       Date:  2009-07-01

7.  Formulation of normal tissue irradiation volumes in Co-60 and Ir-192 HDR ICBT of Ca cervix using Total Reference Air Kerma (TRAK).

Authors:  Ngangom Robert; R P Chauhan; Arun Oinam; Bhavana Rai
Journal:  Rep Pract Oncol Radiother       Date:  2019-10-18

8.  A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy.

Authors:  Tae Hyun Kim; Joo-Young Kim; Dae Kyung Sohn; Yeon-Joo Kim; Yoon-Seok Lee; Sung Ho Moon; Sang Soo Kim; Dae Yong Kim
Journal:  Radiat Oncol       Date:  2013-01-31       Impact factor: 3.481

9.  Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy.

Authors:  Primoz Petric; Robert Hudej; Peter Rogelj; Mateja Blas; Barbara Segedin; Helena Barbara Zobec Logar; Johannes Carl Athanasios Dimopoulos
Journal:  Radiol Oncol       Date:  2012-04-11       Impact factor: 2.991

10.  The Relationship Between Late Morbidity and Dose-Volume Parameter of Rectum in Combined Intracavitary/Interstitial Cervix Cancer Brachytherapy: A Mono-Institutional Experience.

Authors:  Ning Zhang; Ying Liu; Dongmei Han; Xin Guo; Zhuang Mao; Wei Yang; Guanghui Cheng
Journal:  Front Oncol       Date:  2021-07-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.